Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CollPlant Biotechnologies Ltd. - Ordinary Shares (NQ:CLGN)

1.650 +0.230 (+16.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 314,412
Open 1.500
Bid (Size) 1.720 (5)
Ask (Size) 1.740 (1)
Prev. Close 1.420
Today's Range 1.420 - 1.700
52wk Range 1.401 - 5.480
Shares Outstanding 10,258,129
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-56.7%
-56.7%
1 Month
-4.6%
-4.6%
3 Month
-48.1%
-48.1%
6 Month
-54.5%
-54.5%
1 Year
-67.6%
-67.6%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Down 100 Points; Chicago PMI Dips In May
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Preview: CollPlant Biotechnologies
Via Benzinga
CollPlant Biotechnologies's Earnings: A Preview
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Via Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Recap: CollPlant Biotechnologies Q3 Earnings
Via Benzinga
Earnings Outlook For CollPlant Biotechnologies
Via Benzinga
Earnings Scheduled For May 28, 2025
Via Benzinga
Earnings Scheduled For March 26, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 27, 2024
Via Benzinga
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For April 4, 2024
Via Benzinga
Earnings Scheduled For November 29, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is CollPlant Biotechnologies Ltd. - Ordinary Shares publicly traded?
Yes, CollPlant Biotechnologies Ltd. - Ordinary Shares is publicly traded.
What exchange does CollPlant Biotechnologies Ltd. - Ordinary Shares trade on?
CollPlant Biotechnologies Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CollPlant Biotechnologies Ltd. - Ordinary Shares?
The ticker symbol for CollPlant Biotechnologies Ltd. - Ordinary Shares is CLGN on the Nasdaq Stock Market
What is the current price of CollPlant Biotechnologies Ltd. - Ordinary Shares?
The current price of CollPlant Biotechnologies Ltd. - Ordinary Shares is 1.650
When was CollPlant Biotechnologies Ltd. - Ordinary Shares last traded?
The last trade of CollPlant Biotechnologies Ltd. - Ordinary Shares was at 06/16/25 04:00 PM ET
What is the market capitalization of CollPlant Biotechnologies Ltd. - Ordinary Shares?
The market capitalization of CollPlant Biotechnologies Ltd. - Ordinary Shares is 16.93M
How many shares of CollPlant Biotechnologies Ltd. - Ordinary Shares are outstanding?
CollPlant Biotechnologies Ltd. - Ordinary Shares has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.